We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

190 hedge funds and large institutions have $3.58B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 101 increasing their positions, 39 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 39

6% less funds holding

Funds holding: 202 → 190 (-12)

15% less capital invested

Capital invested by funds: $4.21B → $3.58B (-$626M)

32% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 38

48% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $2.89M

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
190
Holders Change
-12
Holders Change %
-5.94%
% of All Funds
3.31%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
26
Increased
101
Reduced
39
Closed
38
Calls
$1.5M
Puts
$2.89M
Net Calls
-$1.4M
Net Calls Change
-$5.84M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$99.6M
2
BlackRock
BlackRock
New York
+$50.1M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$36.6M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$28.3M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$27.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$245M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$47M
3
CCM
Consonance Capital Management
New York
-$42.6M
4
Victory Capital Management
Victory Capital Management
Texas
-$33.7M
5
DCM
Driehaus Capital Management
Illinois
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
51
Peregrine Capital Management
Minnesota
$9.6M +$1.92M +25,968 +27%
IBT
52
International Biotechnology Trust
United Kingdom
$9.48M +$2.96M +40,000 +49%
TCM
53
Tekla Capital Management
Massachusetts
$9.31M – – –
EA
54
Emerald Advisers
Pennsylvania
$9.07M -$4.75M -64,257 -36%
Two Sigma Advisers
55
Two Sigma Advisers
New York
$8.64M -$458K -6,200 -5%
Voloridge Investment Management
56
Voloridge Investment Management
Florida
$7.96M +$5.5M +74,394 +269%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$7.7M +$684K +9,254 +10%
Axa
58
Axa
France
$7.56M +$1.14M +15,390 +19%
OCM
59
Osterweis Capital Management
California
$7.38M +$2.87M +38,870 +70%
Swiss National Bank
60
Swiss National Bank
Switzerland
$7.04M -$244K -3,300 -4%
Allianz Asset Management
61
Allianz Asset Management
Germany
$7.04M +$2.47M +33,373 +59%
DM
62
Deerfield Management
New York
$6.54M – – –
Deutsche Bank
63
Deutsche Bank
Germany
$6.31M +$1.84M +24,897 +44%
CC
64
Casdin Capital
New York
$5.85M – – –
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$4.99M +$1.52M +20,541 +47%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$4.95M +$523K +7,075 +13%
FAM
67
Fred Alger Management
New York
$4.85M -$112K -1,520 -2%
Citigroup
68
Citigroup
New York
$4.75M +$1.4M +18,942 +45%
State of Wisconsin Investment Board
69
State of Wisconsin Investment Board
Wisconsin
$4.64M +$436K +5,900 +11%
Neuberger Berman Group
70
Neuberger Berman Group
New York
$4.37M +$1.2M +16,171 +41%
WCM Investment Management
71
WCM Investment Management
California
$4.24M +$154K +2,084 +4%
Morgan Stanley
72
Morgan Stanley
New York
$4.2M +$3.47M +46,909 +673%
Prudential Financial
73
Prudential Financial
New Jersey
$4.18M +$628K +8,497 +19%
GIM
74
Granahan Investment Management
Massachusetts
$4.08M +$217K +2,938 +6%
SBH
75
Segall Bryant & Hamill
Illinois
$4.04M +$209K +2,824 +6%
1 2
3
4 5

TPTX Hedge Fund Activity: Q2 2021 in Review

190 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q2 2021, worth a combined $3.58B — down 15% from $4.21B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of TPTX and 26 opened new positions — a net loss of 12 holders — while 39 trimmed existing stakes and 101 added.

The largest buyer was Wellington Management Group, adding an estimated $99.6M. The largest seller was Fidelity Investments, cutting an estimated $245M.

  • 190 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q2 2021, down from 202 in Q1 2021.
  • Funds reported $3.58B of Turning Point Therapeutics, Inc. Common Stock stock for Q2 2021, down 15% quarter-over-quarter.
  • 26 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q2 2021 and 38 closed out, a net change of -12 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q2 2021 was Wellington Management Group, an estimated $99.6M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q2 2021 was Fidelity Investments, an estimated $245M sold.

Based on aggregated 13F filings for Q2 2021.